Pharmaceutical products

Tender description

All regions — 15 February 2021 to 31 January 2023 (23.5 months) 23.5 months with an option or options to extend (at the discretion of the authority) for a period or periods up to a total of 47 months. NHS National Generic Pharmaceuticals for the supply of Inhalation Anaesthetics and Vaporisers Offer reference number: CM/PHG/20/5626 Period of framework agreement: 23.5 months with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 23.5 months. The total maximum duration of the framework agreement to be no more than 47 months. Potential periods of call-offs under the framework agreement: all regions — 15 February 2021 to 31 January 2023 (23.5 months). NHS National Generic Pharmaceuticals for the supply of Inhalation Anaesthetics and Vaporisers Offer reference number: CM/PHG/20/5626 Period of framework agreement: 23.5 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 23.5 months. The total maximum duration of the framework agreement to be no more than 47 months. Potential periods of call-offs under the framework agreement: all regions — 15 February 2021 to 31 January 2023 (23.5 months). NHS National Generic Pharmaceuticals for the supply of Inhalation Anaesthetics and Vaporisers Offer reference number: CM/PHG/20/5626 Period of framework agreement: 23.5 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 23.5 months. The total maximum duration of the framework agreement to be no more than 47 months Potential periods of call-offs under the framework agreement: all regions — 15 February 2021 to 31 January 2023 (23.5 months). NHS National Generic Pharmaceuticals for the supply of Inhalation Anaesthetics and Vaporisers Offer reference number: CM/PHG/20/5626 Period of framework agreement: 23.5 months with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 23.5 months. The total maximum duration of the framework agreement to be no more than 47 months. Potential periods of call-offs under the framework agreement: all regions — 15 February 2021 to 31 January 2023 (23.5 months).